SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001546927-15-000191
Filing Date
2015-07-06
Accepted
2015-07-06 17:07:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 cambercatabasisform13gfiled.htm SC 13G 41159
2 JOINT FILING AGREEMENT cambercatabasisformgex1filed.htm EX-1 2584
  Complete submission text file 0001546927-15-000191.txt   45301
Mailing Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88910 | Film No.: 15974193
SIC: 2834 Pharmaceutical Preparations